Moxifloxacin

Form: Tablets & Opthalmic solution

Strength: Tab- 400 mg; Opthalmic solution- 0.5% (5 mg/mL)

Reference Brands: Avelox®, Avalox®(EU); Avelox®, Vigamox®(US)

Category: Respiratory Disorder

Moxifloxacin is a fourth-generation fluoroquinolone antibiotic used to treat respiratory tract infections, sinusitis, skin infections, and intra-abdominal infections. It is available in the US and EU in multiple forms including 400 mg tablets, 400 mg/250 mL IV infusion, and 0.5% ophthalmic solution. Marketed under brand names such as Avelox®, Avalox®, and Vigamox®, Moxifloxacin is known for its once-daily dosing, excellent tissue penetration, and broad-spectrum antibacterial activity. Widely prescribed for both inpatient and outpatient care, it is a top product for B2B pharma, PCD franchise, and international export, serving as a critical antibiotic in global healthcare supply chains.